| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1056/NEJM199511303332202 |
| P698 | PubMed publication ID | 7477144 |
| P2093 | author name string | Early Breast Cancer Trialists' Collaborative Group | |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1444-1455 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials | |
| P478 | volume | 333 |
| Q41345528 | "One to three" or "four or more"?: selecting patients for postmastectomy radiation therapy |
| Q44947677 | 3-D conformal photon boost in the treatment of early stage breast cancer: four year follow up results. |
| Q47104227 | 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer |
| Q53147457 | A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer. |
| Q74682555 | A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger |
| Q47765341 | A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes |
| Q36828084 | A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT. |
| Q73174011 | A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients |
| Q36733572 | A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer |
| Q53001341 | A method for analyzing disease-specific mortality with missing cause of death information. |
| Q77052329 | A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer |
| Q76338418 | A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer |
| Q35971024 | A review of current practices in breast conservation surgery in the UK. |
| Q57618439 | A user's guide to evidence-based oncology |
| Q36890168 | Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies |
| Q77381685 | Accurate staging of women with breast cancer |
| Q40046781 | Adenovirus expressing mutant p27kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer |
| Q33391830 | Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis |
| Q42767347 | Adjuvant irradiation for breast cancer |
| Q33943639 | Adjuvant radiotherapy after breast conserving surgery for breast cancer. Arbiter |
| Q33943634 | Adjuvant radiotherapy after breast conserving surgery for breast cancer. Contra |
| Q33943629 | Adjuvant radiotherapy after breast conserving surgery for breast cancer. Pro. |
| Q47623926 | Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort? |
| Q33951978 | Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link |
| Q77087330 | Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials |
| Q36680818 | Adjuvant therapy for patients who have node-positive breast cancer |
| Q41172478 | Adjuvant therapy in breast cancer. Optimal use in the elderly |
| Q35570862 | Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer |
| Q36514830 | Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy |
| Q33654566 | An update on radiation therapy in breast cancer |
| Q47382530 | Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning |
| Q33710117 | Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institution |
| Q37700867 | Assessing cardiac injury in mice with dual energy-microCT, 4D-microCT, and microSPECT imaging after partial heart irradiation |
| Q40815799 | Assessing the cost-effectiveness of postmastectomy radiation therapy |
| Q36809052 | Attitudes towards breast conservation in patients aged over 70 with breast cancer |
| Q73743204 | Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer |
| Q36310494 | Autophagy Inhibition to Increase Radiosensitization in Breast Cancer |
| Q35976013 | Axillary Irradiation as an Imperative Alternative to Axillary Dissection in Clinically Lymph Node-Negative but Sentinel Node-Positive Breast Cancer Patients? |
| Q30239832 | Axillary treatment for operable primary breast cancer. |
| Q92120577 | BNP as a potential biomarker for cardiac damage of breast cancer after radiotherapy: a meta-analysis |
| Q93906481 | Benefits of post-mastectomy radiotherapy |
| Q73882964 | Benefits of post-mastectomy radiotherapy |
| Q51721666 | Breast Cancer OncoGuia. |
| Q33446778 | Breast cancer (non-metastatic) |
| Q55176357 | Breast cancer (non-metastatic). |
| Q33841167 | Breast cancer and aging. Clinical interactions |
| Q41441758 | Breast cancer in older women. |
| Q78022709 | Breast cancer in the eastern province of Saudi Arabia |
| Q37153908 | Breast cancer in young women and its impact on reproductive function |
| Q33747672 | Breast cancer screening, diagnosis, and treatment |
| Q36715983 | Breast cancer subtypes: response to radiotherapy and potential radiosensitisation |
| Q36673622 | Breast cancer treatment in clinical practice compared to best evidence and practice guidelines |
| Q34042004 | Breast conservation in the 21st century |
| Q43747290 | Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience |
| Q57807613 | Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database |
| Q53659649 | Breast radiotherapy with inclusion of internal mammary nodes: a comparison of techniques with three-dimensional planning. |
| Q73297849 | Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? |
| Q77891874 | Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer |
| Q74403079 | Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy |
| Q34153737 | Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy |
| Q73755443 | Cellular radiosensitivity and complication risk after curative radiotherapy |
| Q60386436 | Changes in survival after breast cancer: improvements in diagnosis or treatment? |
| Q83610724 | Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beams |
| Q33428326 | Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients |
| Q73594784 | Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer |
| Q35743986 | Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy |
| Q33183149 | Clinical relevance of biologic factors in male breast cancer |
| Q34337369 | Commentary--surgical decisions after breast cancer: can patients be too involved in decision making? |
| Q91789524 | Comparison Of Accelerated Partial Breast Radiation Therapy And External Beam Radiation Therapy By Treatment Planning Indices |
| Q53428744 | Comparison of photon with electron boost in treatment of early stage breast cancer. |
| Q36943147 | Competing causes of death for women with breast cancer and change over time from 1975 to 2003. |
| Q37185964 | Concurrent chemoradiotherapy in adjuvant treatment of breast cancer |
| Q33696577 | Consensus Statement on postmastectomy radiation therapy |
| Q83532345 | Consensus of the Spanish Society of Radiation Oncology (SEOR) Brachytherapy Group on Brachytherapy in breast cancer |
| Q26744320 | Contralateral prophylactic mastectomy: current perspectives |
| Q33721096 | Contribution of randomised controlled trials to understanding and management of early breast cancer |
| Q34744477 | Coordination of care for early-stage breast cancer patients |
| Q47383999 | Correlation between breast tumour size and level of axillary lymph node involvement |
| Q34599091 | Correlation of mammographic calcifications with Her-2/neu overexpression in primary breast carcinomas |
| Q73876814 | Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast |
| Q37360560 | Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) "boost". |
| Q84949042 | Cosmetic outcome and percentage of breast volume excision in oncoplastic breast conserving surgery |
| Q53241402 | Cosmetic outcome of breast conservative treatment for early stage breast cancer. |
| Q72998870 | Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction |
| Q40891979 | Current controversies in the application of meta-analysis (with special reference to oncological treatments) |
| Q73407439 | Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients |
| Q36741163 | Disparities in breast cancer treatment and survival for women with disabilities |
| Q34158859 | Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer |
| Q35014628 | Does regional treatment improve the survival in patients with operable breast cancer? |
| Q35996817 | Ductal carcinoma in situ: recent advances and future prospects. |
| Q35753021 | Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy |
| Q37053808 | Early breast cancer in the elderly: assessment and management considerations |
| Q34678777 | Early operable breast cancer |
| Q43960811 | Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis |
| Q84854563 | Early stage breast cancer and radiotherapy: update |
| Q81264819 | Early stage breast cancer conserving treatment: high dose rate brachytherapy boost to the tumour bed |
| Q39588563 | Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995. |
| Q34054354 | Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials |
| Q29547513 | Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials |
| Q29031162 | Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials |
| Q37041093 | Effects of supervised exercise therapy in patients receiving radiotherapy for breast cancer |
| Q73792149 | Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial |
| Q33879820 | Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy |
| Q34441602 | Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study. |
| Q37421810 | Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). |
| Q35182953 | Evidence-based indications for postmastectomy irradiation |
| Q35062547 | Evidence-based medicine: its effect on treatment recommendations as illustrated by the changing role of postmastectomy irradiation to treat breast cancer |
| Q33504879 | Evolution of breast cancer management in Ireland: a decade of change |
| Q73045413 | External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer |
| Q33178912 | Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST). |
| Q36239594 | Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes |
| Q26471067 | Fraction size in radiation therapy for breast conservation in early breast cancer |
| Q24236396 | Fraction size in radiation treatment for breast conservation in early breast cancer |
| Q24242790 | Fraction size in radiation treatment for breast conservation in early breast cancer |
| Q43673656 | Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes |
| Q29615523 | Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer |
| Q30570778 | Global collaborative networks on meta-analyses of randomized trials published in high impact factor medical journals: a social network analysis |
| Q36615279 | Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy. |
| Q36698389 | HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer |
| Q43230819 | Harmful impact of EU clinical trials directive |
| Q47634330 | Health technology assessment in England and Wales |
| Q51442133 | High-dose-rate brachytherapy for early breast cancer: an ambulatory technique. |
| Q73446693 | Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) |
| Q82317830 | How do I treat "triple-negative" disease |
| Q24235527 | Hyperfractionated or accelerated radiotherapy for head and neck cancer |
| Q36584651 | Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis |
| Q40590819 | Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients |
| Q34470038 | IMRT sparing of normal tissues in locoregional treatment of breast cancer |
| Q36894993 | Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082. |
| Q47591379 | Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis |
| Q33614789 | Impact of physician-patient discussions on patient satisfaction |
| Q43897616 | Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis |
| Q61903165 | Implementation of 3D-virtual brachytherapy in the management of breast cancer: A description of a new method of interstitial brachytherapy |
| Q73415846 | Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant |
| Q47271171 | Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Columbia |
| Q52051017 | Influence of irradiation on therapy-associated psychological distress in breast carcinoma patients. |
| Q46538580 | Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group |
| Q77891858 | Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study |
| Q34695895 | Intensity-modulated radiotherapy of the female breast |
| Q37657782 | Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. |
| Q101353516 | Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial |
| Q49885178 | Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer? |
| Q30250289 | Is the false-positive rate in mammography in North America too high? |
| Q33667626 | Is the use of radiation therapy after mastectomy cost-effective? |
| Q73305333 | Is there still a place for axillary dissection in breast cancer? |
| Q26830129 | Landmark trials affecting the surgical management of invasive breast cancer |
| Q37368064 | Lessons learned from the Decision Board: a unique and evolving decision aid |
| Q64318921 | Local-Regional Metastases and Mortality After Sentinel Biopsy and Complete Dissection of Axillary Lymph Nodes in Patients with Early Invasive Breast Cancer |
| Q40807197 | Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. |
| Q43962683 | Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy |
| Q35239625 | Locoregional therapy of locally advanced breast cancer: a clinical practice guideline |
| Q36300961 | Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck |
| Q80960669 | Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries |
| Q78944692 | Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system |
| Q74270101 | Long-term results of neoadjuvant radiation therapy for breast cancer |
| Q49186808 | Long-term results with resection of radiation-induced soft tissue sarcomas |
| Q61903198 | Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: Preliminary results of a pilot trial |
| Q30791294 | Mastectomy by Inverted Drip Incision and Immediate Reconstruction: Data From 510 Cases |
| Q90244199 | Mastectomy versus breast-conservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making |
| Q57407566 | Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials |
| Q34297768 | Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery |
| Q34009241 | Meta-analysis in hematology and oncology |
| Q37153027 | Meta-analysis in medical research: potentials and limitations |
| Q28222536 | Meta-analysis: some clinical and statistical contributions in several medical disciplines |
| Q33779196 | Metastatic breast cancer |
| Q34479775 | Minimally invasive surgery in breast cancer treatment |
| Q31064931 | Minimally invasive therapy for the treatment of breast tumours |
| Q36646609 | Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference? |
| Q50564769 | Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis |
| Q74657306 | Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada |
| Q24241534 | Multi-agent chemotherapy for early breast cancer |
| Q33932014 | Multidisciplinary care for patients with breast cancer |
| Q45206109 | Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation |
| Q77224816 | Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer |
| Q36542675 | New trends in breast cancer management: is the era of immediate breast reconstruction changing? |
| Q35182933 | New trends in breast conservation therapy |
| Q44704525 | No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer |
| Q34346887 | Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial |
| Q35684426 | Oncoplastic approaches to breast conservation |
| Q38549512 | Outcome in breast cancer managed without an initial axillary lymph node dissection |
| Q47701282 | Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy |
| Q28749604 | Outcomes following local therapy for early-stage breast cancer in non-trial populations |
| Q24241508 | Ovarian ablation for early breast cancer |
| Q77911491 | Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation |
| Q51487931 | Papillary carcinoma of the male breast: report of a case. |
| Q24193898 | Partial breast irradiation for early breast cancer |
| Q24243437 | Partial breast irradiation for early breast cancer |
| Q26471072 | Partial breast irradiation for early breast cancer |
| Q37331382 | Participation in treatment decision-making by women with early stage breast cancer |
| Q35883324 | Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors |
| Q37043609 | Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy |
| Q35249333 | Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft |
| Q34479788 | Post-mastectomy irradiation: the continuing controversy |
| Q24186275 | Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes |
| Q24203952 | Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes |
| Q33784165 | Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? |
| Q30724455 | Post-surgery radiation in early breast cancer: survival analysis of registry data |
| Q33667584 | Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue |
| Q26823624 | Postmastectomy radiation therapy: an overview for the practicing surgeon |
| Q36389881 | Postmastectomy radiotherapy in intermediate-risk patients: the gray zone |
| Q34397789 | Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes |
| Q44942407 | Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons |
| Q77911483 | Postmastectomy radiotherapy: randomized trials |
| Q33667610 | Postmastectomy radiotherapy: toxicities and techniques to reduce them |
| Q44264688 | Postoperative radiotherapy for lung cancer: the breast cancer story all over again? |
| Q78258300 | Postoperative radiotherapy in high-risk postmenopausal breast cancer |
| Q50563448 | Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. |
| Q79324730 | Practice patterns in breast cancer surgery: Canadian perspective |
| Q24245030 | Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma |
| Q74261664 | Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer |
| Q74444684 | Prediction of nipple and areola involvement in breast cancer |
| Q37362782 | Predictive parameters for selection of electronic tissue compensation radiotherapy in early-stage breast cancer patients after breast-conserving surgery |
| Q56568587 | Predictors of Unemployment After Breast Cancer Surgery: A Systematic Review and Meta-Analysis of Observational Studies |
| Q36368893 | Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. |
| Q54504164 | Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. |
| Q44630121 | Predictors of reexcision findings and recurrence after breast conservation. |
| Q35132326 | Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study |
| Q77115644 | Primary biliary cirrhosis in patients with breast cancer: studying the link |
| Q36144983 | Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer |
| Q47207357 | Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients. |
| Q44263746 | Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy |
| Q36769549 | Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery |
| Q51096264 | Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative G |
| Q58388705 | Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics |
| Q26795690 | Radiation induced heart disease: Pathogenesis, management and review literature |
| Q36587890 | Radiation therapy after breast-conserving surgery |
| Q33667568 | Radiation therapy as an adjunct to primary surgery in early stage breast cancer: biological and clinical rationale |
| Q37602386 | Radiation therapy for early breast cancer |
| Q36988934 | Radiation therapy resources and guideline-concordant radiotherapy for early-stage breast cancer patients in an underserved region |
| Q35026054 | Radiation-associated cardiovascular disease |
| Q74266794 | Radical versus conservative cancer surgery: an anachronism? |
| Q34558250 | Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer |
| Q24241493 | Radiotherapy for early breast cancer |
| Q73837076 | Radiotherapy for early breast cancer: was a comprehensive overview of trials needed? |
| Q34247346 | Radiotherapy in the management of early breast cancer |
| Q74261672 | Radiotherapy of breast cancer after breast-conserving surgery: an improved technique using mixed electron-photon beams with a multileaf collimator |
| Q73666678 | Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group |
| Q33687673 | Recent advances in the surgical care of breast cancer patients |
| Q43869499 | Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery |
| Q39663945 | Relative biological effectiveness of photon energies used in brachytherapy and intraoperative radiotherapy techniques for two breast cancer cell lines |
| Q37601943 | Research on different techniques in breast cancer radiotherapy |
| Q35581379 | Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality. |
| Q77931167 | Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer |
| Q35091186 | Risk of lymphedema after regional nodal irradiation with breast conservation therapy |
| Q41854049 | Risk of needle-track seeding after diagnostic image-guided core needle biopsy in breast cancer |
| Q33667592 | Role of postmastectomy radiotherapy: A medical oncology perspective |
| Q38400679 | Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis |
| Q80839230 | Role of resection margins in patients treated with breast conservation surgery |
| Q40683572 | Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study. |
| Q36916416 | STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers |
| Q24202273 | Screening for breast cancer with mammography |
| Q24234793 | Screening for breast cancer with mammography |
| Q24240411 | Screening for breast cancer with mammography |
| Q24244332 | Screening for breast cancer with mammography |
| Q36107120 | Sentinel lymph node biopsy of the internal mammary chain in breast cancer. |
| Q74320067 | Serial pathological examination of resected specimens as a basic procedure in safe conservative breast cancer treatment |
| Q33855425 | Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? |
| Q77091235 | Shoulder movement after the treatment of early stage breast cancer |
| Q42747901 | Solitary bone metastasis beneath the shoulder shield: coincidence or cause? |
| Q31014536 | Spectrotemporal CT data acquisition and reconstruction at low dose |
| Q36925795 | Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform |
| Q52900179 | Summing up evidence: one answer is not always enough. |
| Q24236172 | Surgery followed by postoperative radiotherapy versus surgery alone for localized cancer of the esophagus |
| Q24242186 | Surgery followed by postoperative radiotherapy versus surgery alone for localized cancer of the esophagus |
| Q28661521 | Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? |
| Q33218839 | Surgical management of early stage invasive breast cancer: a practice guideline. |
| Q35828253 | Surgical treatment of early stage breast cancer in elderly: an international comparison |
| Q38594810 | Surgical treatment of nonpalpable primary invasive and in situ breast cancer |
| Q76383776 | Survival after surgical treatment of breast cancer |
| Q74051434 | Survival of women after breast conserving surgery for early stage breast cancer |
| Q31991310 | Systematic reviews using individual patient data: a map for the minefields? |
| Q24241483 | Tamoxifen for early breast cancer |
| Q29619251 | Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group |
| Q34093366 | Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. |
| Q28285969 | Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial |
| Q36755485 | Template-based breast IMRT planning for increased workload efficiency |
| Q36611787 | Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer |
| Q35177617 | Testing the treatment effect on competing causes of death in oncology clinical trials |
| Q26795717 | The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation |
| Q36869207 | The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy |
| Q33631121 | The changing role of surgery in the diagnosis and treatment of cancer |
| Q33931991 | The changing role of the surgical oncologist |
| Q72998875 | The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy |
| Q53591566 | The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial. |
| Q33757672 | The crucial role of adjuvant irradiation after surgery for breast cancer |
| Q78362400 | The curative role of radiotherapy in the treatment of operable breast cancer |
| Q36781127 | The debate on breast cancer screening with mammography is important |
| Q77747957 | The declining use of axillary dissection in patients with early stage breast cancer |
| Q41664517 | The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival. |
| Q35180556 | The follow-up of breast cancer |
| Q34041991 | The impact of loco-regional radiotherapy on the survival of breast cancer patients. Arbiter |
| Q34041985 | The impact of loco-regional radiotherapy on the survival of breast cancer patients. Contra |
| Q34041979 | The impact of loco-regional radiotherapy on the survival of breast cancer patients. Pro. |
| Q50615497 | The impact of radiation on early breast carcinoma survival. A Bayesian analysis. |
| Q73081820 | The influence of patient geometry on the selection of chest wall irradiation techniques in post-mastectomy breast cancer patients |
| Q73173993 | The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy |
| Q43774018 | The link between local recurrence and distant metastases in human breast cancer |
| Q33873084 | The management of ductal and lobular breast cancer |
| Q36769061 | The preferred treatment for young women with breast cancer--mastectomy versus breast conservation |
| Q74026769 | The quality of early-stage breast cancer care |
| Q59721943 | The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures |
| Q33971420 | The role of meta-analyses in assessing cancer treatments |
| Q41442068 | The role of radiation therapy after local excision of invasive and noninvasive breast cancer. |
| Q33779190 | The role of radiation therapy for primary breast cancer |
| Q34972167 | The role of radiotherapy-resistant stem cells in breast cancer recurrence |
| Q73929248 | The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy |
| Q48840056 | The trials of Dr. Bernard Fisher: a European perspective on an American episode |
| Q73303141 | Treatment of mammographically detected minimal breast cancer in an older woman |
| Q33972964 | Understanding the factors associated with the surgical management of early breast cancer |
| Q73744109 | Use of electronic portal imaging to assess cardiac irradiation in breast radiotherapy |
| Q31140437 | Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data |
| Q73335120 | Use of primary breast carcinoma characteristics to predict lymph node metastases |
| Q46934210 | Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsured |
| Q35851755 | Using second harmonic generation to predict patient outcome in solid tumors. |
| Q38916555 | Validation of the electronic version of the BREAST-Q in the army of women study |
| Q55086184 | What Drives Patient Choice: Preferences for Approaches to Surgical Treatments for Breast Cancer Beyond Traditional Clinical Benchmarks. |
| Q74119692 | Will the sentinel lymph node (SLN) stand a second time--SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure |
| Q77734723 | [Influence of locoregional irradiation on local control and survival in breast cancer] |
| Q77762615 | [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?] |
| Q73315349 | [Oncology '96] |
| Q73609479 | [Postmastectomy locoregional radiotherapy for breast cancer: literature review] |
| Q74259001 | [Postoperative radiotherapy in high risk patients with breast cancer and adjuvant chemotherapy] |
| Q81379597 | [Single fraction boost with high dose rate interstitial brachytherapy in conservative treatment of breast carcinoma] |
| Q87919255 | [The pendulum swings back - lymphatic irradiation of breast cancer is in favor again] |
| Q53904635 | [Treatment of breast cancer: its progress and its limits] |
Search more.